Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Illumina, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Illumina appointed Daniel M. Skovronsky, M.D., Ph.D. as a new independent director, expanding the Board from nine to ten members effective immediately. This governance enhancement reflects the company's commitment to strategic oversight and board composition.
Key Takeaways
Board size increased from 9 to 10 members with immediate appointment of Dr. Daniel M. Skovronsky
Dr. Skovronsky qualifies as an independent director under applicable regulations with no conflicting transactions
2 more takeaways